Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Namita A. Goyal, M.D.
WARNING LETTER
•Namita A. Goyal, M.D.•June 23, 2023

Namita A. Goyal, M.D. – FDA Warning Letter, Jun 23, 2023

Record Details

The FDA issued a Warning Letter to Dr. Goyal following a Bioresearch Monitoring (BIMO) inspection from June 12-23, 2023, at a clinical study site, reviewing the conduct of a clinical investigation. The inspection revealed significant violations of regulations governing clinical studies involving investigational products (21 CFR 312 and 50), leading to a Form FDA 483 and subsequent Warning Letter despite the firm's responses. Key violations include the failure to conduct the investigation according to the signed investigator statement, investigational plan, and applicable regulations (21 CFR § 312.60), encompassing enrolling ineligible subjects, administering investigational product prior to release, and allowing unauthorized personnel to perform study tasks. The firm also failed to obtain legally effective informed consent (21 CFR § 50.20), with instances of non-subjects signing consent forms, un-impartial witnesses, and genetic testing performed without documented consent. Furthermore, there was a failure to assure IRB compliance and obtain approval for changes in research activity (21 CFR § 312.66), specifically regarding IRB members with conflicting interests and the use of an unapproved screening questionnaire. Significant deficiencies were also noted in preparing and maintaining adequate and accurate case histories (21 CFR § 312.62(b)), including unrecorded adverse events, missing bone marrow aspiration records, unreviewed hospitalization records, unrecorded concomitant medications, and unjustified duplicate ECG assessments. Additional concerns highlighted compromised data reliability due to an uncalibrated spirometer affecting 50 SVCs and inaccurate, non-contemporaneous protocol training logs. The FDA expressed significant concerns about the validity and integrity of all data collected at the site. Dr. Goyal is required to respond within 15 working days with specific corrective and preventative actions, including documentation, to address these systemic compliance issues and prevent recurrence, or face potential regulatory action.

Company
Namita A. Goyal, M.D.
Inspection date
June 23, 2023
Product type
Biologics
Office
Center for Biologics Evaluation and Research
People
  • Melissa J. Mendoza (Director)
  • Eric S. Pittman ( Director, Bioresearch Monitoring Division (West) and FDA Delegate to the OECD Working Party on GLPs)
View Company Profile

ID · 10e2319c-97cc-49b6-ae50-effb34334ca6

Violation Codes7
21 CFR 31221 CFR 5021 CFR 312.6021 CFR 50.2021 CFR 312.6621 CFR 312.62(b)21 CFR 56.107(e)

Full citation text and observation details available on the Dashboard.

Other documents for Namita A. Goyal, M.D.
  • 483 - 2023-06-23June 23, 2023

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Namita A. Goyal, M.D.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.